Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEDI-528 in uncontrolled asthma
NCT00968669Phase 2Completed
- Sponsor
- MedImmune
- Start
- Dec 2009
- Primary completion
- Nov 2011
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 10
01
Overview
A Phase 2 trial of enokizumab in asthma, sponsored by MedImmune. Started Dec 2009; status: completed.
02
Drugs
enokizumab
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00968669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00968669.